Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel in Urothelial Carcinoma After Platinum Chemotherapy
NCT01437488Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Feb 2012
- Primary completion
- Aug 2014
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel ginsenoside liposome injection in urothelial carcinoma (UC), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Feb 2012; status: completed.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01437488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01437488.